A prospective pilot evaluation of urinary and immunohistochemical markers as predictors of clinical stage of urothelial carcinoma of the bladder

BJU International

Volumn 85, Issue 9, 2000, Pages 1027-1032

  Krupski, T ^a   Moskaluk, C ^a   Boyd, J C ^a   Theodorescu, Dan ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Angiogenesis; Bladder neoplasm; BTA; Cytology; Epidermal growth factor receptor; p53; Prognosis; Tumour markers

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53; TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; COLORIMETRY; CYTOLOGY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL ANALYSIS; TRANSURETHRAL RESECTION; URINALYSIS;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROCIRCULATION; MIDDLE AGED; NEOPLASM STAGING; PILOT PROJECTS; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

EID: 0034079473     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2000.00676.x     Document Type: Article

References (34)

1. Douglas RM, Kaufman DS, Zietman AL, Althausen AF, Heney NM, Shipley WU. Conservative surgery, patient selection, and chemoradiation as organ-preserving treatment for muscle-invading bladder cancer. Semin Oncol 1996; 23: 614-20
2. Herrell SD, Trachtenberg J, Theodorescu D. Staging pelvic lymphadenectomy for localized carcinoma of the prostate: a comparison of 3 surgical techniques. J Urol 1997; 157: 1337-9
3. Ragde H, Elgamal AAA, Snow PB et al. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-Gray external beam irradiation in the treatment of patients with clinically localized low to high Gleason grade prostate carcinoma. Cancer 1998; 83: 989-1001
4. Chasko SB, Gray GF, McCarron Jp Jr. Urothelial neoplasia of the upper urinary tract. Pathol Ann 1981; 16: 127-53
5. Heney NM, Nocks BN, Daly JJ, Blitzer PH, Parkhurst EC.Prognostic factors in carcinoma of the ureter. J Urol 1981; 125: 632-6
6. Theodorescu D, Broder SR, Boyd JC, Mills SE, Frierson Hf Jr. p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate. J Urol 1997; 158: 131-7
7. Theodorescu D, Broder SR, Boyd JC, Mills SE, Frierson Hf Jr. Cathepsin D and chromogranin A as predictors of long term disease specific survival after radical prostatectomy for localized carcinoma of the prostate. Cancer 1997; 80: 2109-19
8. Nguyen PL, Swanson PE, Jaszcz W et al. Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder. A multivariate survival analysis. Am J Clin Pathol 1994; 101: 166-76
9. Chow NH, Liu HS, Lee EI et al. Significance of urinary epidermal growth factor and its receptor expression in human bladder cancer. Anticancer Res 1997; 17: 1293-6
10. Ravery V, Colombel M, Popov Z et al. Prognostic value of epidermal growth factor-receptor, T138 and T43 expression in bladder cancer, Br J Cancer 1995; 71: 196-200
11. Dalbagni G, Presti Jc Jr, Reuter VE et al. Molecular genetic alterations of chromosome 17 and p53 nuclear overexpression in human bladder cancer. Diag Mol Pathol 1993; 2: 4-13
12. Lianes P, Orlow I, Zhang ZF et al. Altered patterns of MDM2 and TP53 expression in human bladder cancer. J Natl Cancer Inst 1994; 86: 1325-30
13. Soini Y, Turpeenniemi-Hujanen T, Kamel D et al. p53 immunohistochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progression. Br J Cancer 1993; 68: 1029-35
14. Brawer MK, Deering RE, Brown M, Preston SD, Bigler SA. Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity. Cancer 1994; 73: 678-87
15. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993; 143: 401-9
16. O'Brien T, Cranston D, Fuggle S, Bicknell R, Harris AL. Two mechanisms of basic fibroblast growth factor-induced angiogenesis in bladder cancer. Cancer Res 1997; 57: 136-40
17. Philp EA, Stephenson TJ, Reed MW. Prognostic significance of angiogenesis in transitional cell carcinoma of the human urinary bladder. Br J Urol 1996; 77: 352-7
18. Sarosdy MF, deVere White RW, Soloway MS et al. Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer. J Urol 1995; 154: 379-83
19. Ianari A, Sternberg CN, Rossetti A et al. Results of Bard BTA test in monitoring patients with a history of transitional cell cancer of the bladder. Urology 1997; 49: 786-9
20. Sarosdy MF, Hudson MA, Ellis WJ et al. Improved detection of recurrent bladder cancer using the Bard BTA Stat test. Urology 1997; 50: 349-53
21. Ellis WJ, Blumenstein BA, Ishak LM, Enfield DL. Clinical evaluation of the BTA TRAK assay and comparison to voided urine cytology and the Bard BTA test in patients with recurrent bladder tumors. The Multi Center Study Group. Urology 1997; 50: 882-7
22. Heicappell R, Wettig IC, Schostak M et al. Quantitative detection of human complement factor H-related protein in transitional cell carcinoma of the urinary bladder. Eur Urol 1999; 35: 81-7
23. Crane CH, Clark MM, Bissonette EA, Theodorescu D. Prospective evaluation of the effect of ionizing radiation on the bladder tumor-associated (BTA) urine test. Int J Radiat Oncol Biol Phys 1999; 43: 73-7
24. Sobin LH, Wittekind C. TNM Classification of Malignant Tumors, 5th edn. New York: John Wiley & Sons, 1997
25. Bostwick DG, Wheeler TM, Blute M et al. Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies. Urology 1996; 48: 47-57
26. Boyd JC. Mathematical tools for demonstrating the clinical usefulness of biochemical markers. Scand J Clin Lab Invest 1997; Suppl. 227: 46-63
27. Tawfiek ER, Bagley DH. Upper-tract transitional cell carcinoma. urology 1997; 50: 321-9
28. Keeley FX, Kulp DA, Bibbo M, McCue PA, Bagley DH. Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma. J Urol 1997; 157: 33-7
29. Mills SE, Fowler Je Jr. Gleason histologic grading of prostatic carcinoma. Correlations between biopsy and prostatectomy specimens. Cancer 1986; 57: 346-9
30. Iruela-Arispe ML, Dvorak HF. Angiogenesis: a dynamic balance of stimulators and inhibitors. Thromb Haemost 1997; 78: 672-7
31. Dickinson AJ. Prognostic significance of angiogenesis in transitional cell carcinoma of the human urinary bladder. Br J Urol 1996; 78: 808
32. Jaeger TM, Weidner N, Chew K et al. Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer. J Urol 1995; 154: 69-71
33. Bochner BH, Cote RJ. Weidner N et al. Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J Natl Cancer Inst 1995; 87: 1603-12
34. Dinney CPN, Babkowski RC, Antelo M et al. Relationship among cystectomy, microvessel density and prognosis in stage T1 transitional cell carcinoma of the bladder. J Urol 1998; 160: 1285-90